Oragenics, Inc.OGENNYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -34.97% |
| Q2 2025 | -2.48% |
| Q1 2025 | 33.80% |
| Q4 2024 | -35.98% |
| Q3 2024 | -6.84% |
| Q2 2024 | 5.95% |
| Q1 2024 | 80.77% |
| Q4 2023 | -533.29% |
| Q3 2023 | 34.02% |
| Q2 2023 | -7.23% |
| Q1 2023 | -839.95% |
| Q4 2022 | 92.18% |
| Q3 2022 | -7.82% |
| Q2 2022 | 21.81% |
| Q1 2022 | -100.25% |
| Q4 2021 | 47.70% |
| Q3 2021 | -14.90% |
| Q2 2021 | 26.91% |
| Q1 2021 | -18.39% |
| Q4 2020 | 1.95% |
| Q3 2020 | 63.55% |
| Q2 2020 | -137.82% |
| Q1 2020 | -44.21% |
| Q4 2019 | 6.24% |
| Q3 2019 | 20.18% |
| Q2 2019 | -44.52% |
| Q1 2019 | -20.69% |
| Q4 2018 | 0.08% |
| Q3 2018 | -20.89% |
| Q2 2018 | -7.64% |
| Q1 2018 | -45.09% |
| Q4 2017 | 29.33% |
| Q3 2017 | -69.29% |
| Q2 2017 | 38.42% |
| Q1 2017 | 25.87% |
| Q4 2016 | -36.26% |
| Q3 2016 | -527.93% |
| Q2 2016 | 84.85% |
| Q1 2016 | 7.05% |
| Q4 2015 | -19.09% |